Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Syngene International Ltd. ( (IN:SYNGENE) ) has shared an announcement.
Syngene International Limited has announced the availability of the transcript for its Q1 FY2026 earnings call, which took place on July 24, 2025. The transcript is accessible on the company’s website, providing stakeholders with insights into the company’s financial performance and strategic direction for the quarter.
More about Syngene International Ltd.
Syngene International Limited operates in the biotechnology industry, providing services in drug discovery, development, and manufacturing. The company focuses on delivering integrated scientific solutions to the pharmaceutical, biotechnology, and agrochemical sectors.
Average Trading Volume: 28,975
Technical Sentiment Signal: Hold
Current Market Cap: 278.1B INR
See more data about SYNGENE stock on TipRanks’ Stock Analysis page.